A panelist discusses how obtaining a Clinical Laboratory Improvement Amendments (CLIA) waiver is an essential regulatory step for pharmacies to perform point-of-care testing, followed by credentialing with payers to receive reimbursement for these services.
Regulatory Framework and Credentialing
Main Discussion Topics:
Key Points for Physicians:
Notable Insights:
Clinical Significance:
Although regulatory and credentialing processes require an initial investment of time, they establish the foundation for pharmacy-based clinical services that can expand health care access points and create sustainable revenue streams through formalized medical billing pathways.